Clinical Trial Update: Determine MTD, Evaluate Efficacy and Safety of Genexol®-PM Plus Carboplatin With Advanced Ovarian Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the maximum tolerated dose and safety, with early efficacy signals, of Genexol®-PM plus carboplatin in advanced ovarian cancer has been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Genexol-PM (paclitaxel)

Snippet

Sponsor: Samyang Biopharmaceuticals Corporation | Conditions: Ovarian Cancer | Phase 1 | Status: COMPLETED